Anika Ruisch is a Technical Advisor with the Health Economics and Financing Team at Management Sciences for Health (MSH). At MSH, she’s been leading the development of a guide on Health Technology Assessment and two costing studies estimating the investment needed to deliver COVID vaccinations in Malawi and seasonal malaria chemoprevention in West and Central Africa.
Anika has over eight years of experience in research, epidemiology, and health economics working in public, private and non-profit settings. Anika received her MSc in epidemiology from the London School of Hygiene and Tropical Medicine and MSc in global health from the University of Copenhagen.
aruisch@msh.org